October is Breast Cancer Awareness Month.
Breast cancer is the most common cancer in women. Although rare, men, on average over the age of 50, get breast cancer too. According to the National Breast Cancer Foundation, in 2020, an estimated 2,620 men will be diagnosed with breast cancer this year in the U.S. During October women and men are encouraged to learn the facts about breast cancer and why screening should be a regular part of your health care.
This Weekly‘s Hot Topics
- This Thursday! Genomic Testing and Targeted Treatment of NSCLC
- California to manufacture cheaper versions of generic drugs
- Nurse practitioners to practice medicine independent of doctors
- Tell Congress to oppose cutting Medicare payments!
This Thursday, October 8, 2020, 5:30pm-6:30pm – MOASC Clinical Webinar. Title: “It’s Precisely the Time for More Precision in Genomic Testing and Targeted Treatment of NSCLC” Presented by: Jacob Sands, M.D., Dana-Farber Cancer Institute. In this activity, oncology experts discuss the roles of genomic testing and targeted treatment in lung cancer. Practical guidance for expanding molecular testing for genomic alterations occurring in non–small cell lung cancer with FDA-approved targeted therapies is explored. To read more click here and go to MOASC News.
A bill that will allow California to manufacture cheaper versions of generic drugs including insulin has been signed into law by Gov. Gavin Newsom. The law requires the state’s Health and Human Services Agency to seek partnerships with drugmakers to make medicines cheaper and more accessible. To read more click here and go to California News.
Centers for Medicare and Medicaid Services (CMS) is scheduled to cut Medicare payments by double digits starting January 1, 2021. Payment cuts of this magnitude will surely strain a health care system that is already stressed by the COVID-19 pandemic and could jeopardize patient access to medically necessary services. To read more click here and go to CMS News.
HHS said it will distribute an additional $20 billion in aid to help health care providers affected by the COVID-19 pandemic. The new funding is meant to blunt the impact of financial losses and increased operating costs caused by the pandemic. To read more click here and go to National News.
To read the complete California Oncology Weekly Newsletter, click on the date below.